To this end, tumor-infiltrating immune cells, gene-expression-based biomarkers, PD-L1 expression level, tumor mutational burden, complete blood count, peripheral blood mononuclear cells, extracellular structural agents, microbiota, and imaging-based biomarkers have been investigated [8,9]. The gene discussed is CD274; the disease is neoplasm.